Literature DB >> 21504819

A computational model for selectivity evaluation of 2-(3,4-dimethoxyphenyl)ethylamine (homoveratrylamine) imprinted polymers towards biogenic compounds.

Teresa Zołek1, Piotr Luliński, Dorota Maciejewska.   

Abstract

A computational model was proposed to evaluate the affinity and selectivity of 2-(3,4-dimethoxyphenyl)ethylamine (homoveratrylamine) imprinted polymers. Four functional monomers: methacrylic acid, 1-vinylimidazole, 4-vinylpyridine, and allylamine were taken into account. Two dielectric constants were used for solvent simulations: a value of ɛ=2.38r(ij) for toluene was used in the analysis of prepolymerization complexes, and a value of ɛ=36r(ij) for methanol-water was used in the investigations of adsorption. Theoretical analysis predicted the highest affinity for the polymer synthesized from methacrylic acid. Experimental results confirmed the finding. The prepolymerization complex formed by homoveratrylamine and four methacrylic acid molecules was used to design the polymer cavity. The selectivity of the polymer was analyzed as a simulation of adsorption of six compounds in the cavity by docking procedure. Selected compounds are structurally related to the template or can be present in biological samples. The designed polymer has high selectivity towards homoveratrylamine. The proposed computational procedure could be used for successful evaluation of the imprinted polymers.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21504819     DOI: 10.1016/j.aca.2011.03.009

Source DB:  PubMed          Journal:  Anal Chim Acta        ISSN: 0003-2670            Impact factor:   6.558


  1 in total

1.  Magnetic Core-Shell Molecularly Imprinted Nano-Conjugates for Extraction of Antazoline and Hydroxyantazoline from Human Plasma-Material Characterization, Theoretical Analysis and Pharmacokinetics.

Authors:  Joanna Giebułtowicz; Natalia Korytowska; Monika Sobiech; Sebastian Polak; Barbara Wiśniowska; Roman Piotrowski; Piotr Kułakowski; Piotr Luliński
Journal:  Int J Mol Sci       Date:  2021-04-01       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.